/clinical/,/clinical/cckm-tools/,/clinical/cckm-tools/content/,/clinical/cckm-tools/content/delegationpractice-protocols/,/clinical/cckm-tools/content/delegationpractice-protocols/inpatient-delegation-protocols/,

/clinical/cckm-tools/content/delegationpractice-protocols/inpatient-delegation-protocols/name-97314-en.cckm

201711325

page

100

UWHC,UWMF,

Tools,

Clinical Hub,UW Health Clinical Tool Search,UW Health Clinical Tool Search,Delegation/Practice Protocols,Inpatient Delegation Protocols

Candida Intertrigo and/or Cutaneous Candidiasis and Peristomal Yeast Infection Medicated Topical Treatment - Adult - Inpatient [39]

Candida Intertrigo and/or Cutaneous Candidiasis and Peristomal Yeast Infection Medicated Topical Treatment - Adult - Inpatient [39] - Clinical Hub, UW Health Clinical Tool Search, UW Health Clinical Tool Search, Delegation/Practice Protocols, Inpatient Delegation Protocols



Delegation Protocol Number: 39

Delegation Protocol Title:
Candida Intertrigo and/or Cutaneous Candidiasis and Peristomal Yeast Infection Medicated Topical Treatment
- Adult - Inpatient

Delegation Protocol Applies To:
University Hospital and The American Center Inpatients

Target Patient Population:
Adult patients with a need for prevention and management of wound, skin & ostomy conditions.

Delegation Protocol Champion:
Edward Lalik, Department of Medicine – Hospitalists

Delegation Protocol Reviewers:
Deborah Johnson, MSN, RN CWOCN – Nursing, Practice Innovation
Lynette Scott, BSN, RN, Nursing, Practice Innovation
Jacqueline Lakosky, BSN, RN-BC – Nursing, Practice Innovation
Jill Monfre, PhD, RN, CWOCN – Nursing, Practice Innovation
Virginia Luger, BSN, RN-BC, CWON – Nursing, Practice Innovation
Linda McKenna, MSN, RN, CWOCN – Nursing, Practice Innovation

Responsible Department:
Department of Nursing

Purpose Statement:
To delegate authority from the patient’s attending physician to RISC (Resource in Skin Care) staff Registered
Nurses (RNs) and CWOCN/COCN/CWON (Certified Wound, Ostomy, Continence Nurse) staff to order
medications for wound, skin and ostomy conditions.

Who May Carry Out This Delegation Protocol:
RISC RNs and CWOCN/COCN/CWON staff in the inpatient setting.

Guidelines for Implementation:
1. The RISC nurse or the CWOCN/COCN/CWONstaff determines a patient has a peristomal yeast infection,
cutaneous candidiasis, or candida intertrigo and is an appropriate candidate (no known allergy) for
medicated topical products.
2. The RISC nurse or the CWOCN/COCN/CWON staff will place an order in the electronic record for the following:
2.1. topical nystatin powder 100,000 Units/g BID for treatment of peristomal yeast infection or
cutaneous candidiasis
2.2. antimicrobial textile (InterDry Ag) replaced every 5 days (or sooner if visibly soiled or saturated) for
relieving the symptoms associated with Intertrigo
3. If the skin condition clinically worsens, an ordering provider will be notified for further clinical evaluation.
4. Once the RISC nurse or the CWOCN/COCN/CWON staff determines a patient no longer needs the
medicated topical product, the order will be discontinued by the RISC nurse or CWOCN/COCN/CWON
staff.

Order Mode: Protocol/Policy, Without Cosign

References:
1. Wound and Skin Care and Cleansing Product Descriptions. UWHC Wound, Skin, Ostomy and Continence
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
11/2017CCKM@uwhealth.org


Care Web site. https://uconnect.wisc.edu/clinical/nursing-hub/wound-skin/ . Accessed November 11,
2016
2. Instructions for Use of InterDry Ag. UWHC Wound, Skin, Ostomy and Continence Care Web site.
https://uconnect.wisc.edu/clinical/nursing-hub/wound-skin/
. Accessed November 11, 2016
3. Bryant RA. Acute & Chronic Wounds. 5th ed. St. Louis , Missouri: Mosby Elsevier; 2016

Approved By:
UW Health Ambulatory Protocol Committee: January 2012; *July 2014; *November 2016
UWHC Antimicrobial Use Subcommittee: January 2012; *July 2014; *November 2016
UWHC Nursing Practice Committee: February 2012; *July 2014; *December 2016
UWHC P&T Committee: February 2012; *July 2014; *December 2016
UWHC Medical Board: March 2012; *July 2014; *January 2017
UW Health Chief Clinical Officer: *July 2014; *December 2016

Effective: January 2017

Scheduled for Review: January 2020

*Expedited Approval Process
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
11/2017CCKM@uwhealth.org